Cell based Assay Market : Overview
Cell biology is currently the biggest revenue contributor among all others , to the life-science tools industry , accounting for approximately 30 % of total sales . Cell based assays can range from cytotoxic assays to metabolic assays and cell proliferation . The development of such cell based assays includes high throughput screening assays , which are used to characterize drug stability for GLP GMP lot release . It also aids in checking drug potency and for drug purification , as well as production support . MOA , such as receptor activation , receptor binding , cell signalling , subcellular localization , and drug internalization can be delineated via cell-based assays following treatment via pharmaceuticals .
Cell based assays are utilized exclusively by pharmaceutical companies , biotechnology companies , academic research institutes , contract research organizations , government institutes , and others . Apart from the many possibilities in the future , cell based assays have already proven their usefulness in research of many life-threatening diseases such as cancer and autoimmune diseases .
Cell Based Assay Market : Region-wise Outlook
Based on geography the market is analyzed under the various regions of North America , Latin America , Europe , Asia-Pacific and the Middle-East & Africa . North America is closely followed by Europe in terms of having the biggest market for cell based assays mainly due to the rising drug related research & development activities , along with , increase in adoption of cell based assay platforms and huge number of pharmaceutical and biotechnology companies in this region . Asia Pacific region is once again expected to show high growth rate in the cell based assays market like in most healthcare markets in next few years .
Key Questions Answered
� Among the many uses of cell based assays , which is the most valuable to the current Healthcare market ?
� Which product segment must be developed to meet the current demands of drug discovery in the healthcare industry ?
� Are the product segments focusing on finding cures for diseases such as cancer and autoimmune diseases getting enough attention in terms of resources dedicated to R & D ?
� How will the increase in government spending on healthcare in the rapidly growing countries of APAC affect the global market ? � What is the status of the current competitive landscape in the cell based assay market ? � Which companies are dominating in the market right now ? What is the best market entry strategy to be followed for new entrants ?